Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
City hospital # 1 / Northern State Medical University,, Arkhangelsk, Russian Federation
Clinica Santa Maria, Santiago, Chile
Konkuk University Medical Center, Seoul, Korea, Republic of
Toronto General Hospital, 200 Elizabeth St., Toronto, Ontario, Canada
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Korea University Medical Center, Anam hospital, Seoul, Seongbuk-gu, Korea, Republic of
Sirilak Suksompong, Bangkok, Thailand
Aarhus University Hospital, Aarhus, Denmark
Fundagio Puigvert, Barcelona, Spain
University Medical Center Groningen, Groningen, Netherlands
Faculty of Medicine, Assiut, Egypt
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.